Key Takeaways
- • CPZ trades at $12.80 with a -13.57% discount to NAV of $14.81, presenting a potential 86.5% gain if the discount narrows to fair value of $24.04 per share, according to fair value analysis.
- • The closed-end fund delivered negative returns in Q1 2026, declining -3.68% on NAV and -5.36% on market price, reflecting broader equity market weakness and the fund's leveraged long/short strategy exposure.
- • CPZ offers an attractive 13.13% annual distribution yield ($0.14 monthly payments), supported by a multi-asset income strategy combining long/short equity exposure with income-generating assets and dynamic leverage management.
- • The fund carries significant leverage risk with 29.21% total leverage ($120 million debt on $410.8 million managed assets) and a 342% debt coverage ratio, alongside a 3.07% total expense ratio that includes 1.35% management fees and 1.15% leverage fees.
- • Year-to-date performance shows CPZ down -12.7%, with one-year returns declining -20.3%, indicating sustained underperformance that reflects both market headwinds and the fund's exposure to equity volatility despite its hedging mandate.
Summary
The Calamos Long/Short Equity & Dynamic Income Trust (CPZ) presents a complex risk-reward profile for income-focused institutional investors, trading at a substantial 13.57% discount to its underlying net asset value (NAV). As of mid-June 2026, the fund traded at $12.80 against a NAV of $14.81, with valuation analysis suggesting fair value of $24.04—implying potential upside of 86.5% if the discount compresses. This discount reflects investor skepticism regarding the fund's recent performance and leverage structure.
Recent performance has been disappointing. In Q1 2026, CPZ declined -3.68% on a NAV basis and -5.36% on market price, continuing a broader downtrend. Year-to-date performance through early 2026 shows CPZ down -12.7%, while one-year returns have deteriorated -20.3%, demonstrating sustained underperformance despite the fund's stated objective of providing risk-managed capital appreciation. Technical analysis suggests the fund remains within a "wide and falling trend," signaling further weakness potential.
The fund's primary appeal lies in its elevated income generation. CPZ offers an annual distribution rate of 13.13%, paid monthly at $0.14 per share, supported by a multi-asset income strategy designed to be less vulnerable to volatile markets. This high yield is sustained through a combination of net investment income, realized gains, and return of capital distributions. The strategy leverages Calamos Investments' long/short equity expertise combined with dynamic asset allocation that adjusts net equity exposure based on market conditions.
However, substantial risks accompany the high yield. The fund employs significant leverage—29.21% of managed assets ($120 million in debt leverage against $410.8 million in total managed assets), with a debt coverage ratio of 342%. The total expense ratio of 3.07% includes 1.35% management fees, 1.15% leverage fees, and 0.44% in dividend and interest expenses on short sales. These costs, combined with leveraged exposure to equity market volatility and below-investment-grade credit exposure, create material downside risk, particularly in rising rate environments. The fund's inception in November 2019 at $20 IPO pricing, now trading significantly below that level, underscores the structural challenges in current market conditions.
For institutional investors, CPZ remains appropriate only for risk-conscious portfolios seeking high current income with explicit understanding of leverage, market volatility, and negative carry dynamics inherent in the strategy.
Recent performance has been disappointing. In Q1 2026, CPZ declined -3.68% on a NAV basis and -5.36% on market price, continuing a broader downtrend. Year-to-date performance through early 2026 shows CPZ down -12.7%, while one-year returns have deteriorated -20.3%, demonstrating sustained underperformance despite the fund's stated objective of providing risk-managed capital appreciation. Technical analysis suggests the fund remains within a "wide and falling trend," signaling further weakness potential.
The fund's primary appeal lies in its elevated income generation. CPZ offers an annual distribution rate of 13.13%, paid monthly at $0.14 per share, supported by a multi-asset income strategy designed to be less vulnerable to volatile markets. This high yield is sustained through a combination of net investment income, realized gains, and return of capital distributions. The strategy leverages Calamos Investments' long/short equity expertise combined with dynamic asset allocation that adjusts net equity exposure based on market conditions.
However, substantial risks accompany the high yield. The fund employs significant leverage—29.21% of managed assets ($120 million in debt leverage against $410.8 million in total managed assets), with a debt coverage ratio of 342%. The total expense ratio of 3.07% includes 1.35% management fees, 1.15% leverage fees, and 0.44% in dividend and interest expenses on short sales. These costs, combined with leveraged exposure to equity market volatility and below-investment-grade credit exposure, create material downside risk, particularly in rising rate environments. The fund's inception in November 2019 at $20 IPO pricing, now trading significantly below that level, underscores the structural challenges in current market conditions.
For institutional investors, CPZ remains appropriate only for risk-conscious portfolios seeking high current income with explicit understanding of leverage, market volatility, and negative carry dynamics inherent in the strategy.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.